6:33 PM ET
10-Q
Financial Results
Tevogen Q3 2026 Results: Net Loss of $7M, Loss Widens
Tevogen Inc. reported a net loss of $18.2 million for the nine months ended September 30, 2026, compared to $21.6 million in the prior year period. The company continues to operate with a significant stockholders' deficit of $11.3 million and relies on financing activities, including a $3.0 million loan and $3.0 million from pre-funded warrants, to fund its biotechnology and AI initiatives.
- Key figure
- Net loss $7M